PEMAZYRE Trademark

Trademark Overview

On Tuesday, March 6, 2018, a trademark application was filed for PEMAZYRE with the United States Patent and Trademark Office. The USPTO has given the PEMAZYRE trademark a serial number of 87822632. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, October 22, 2025. This trademark is owned by Incyte Holdings Corporation. The PEMAZYRE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders [ ; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders ]
pemazyre

General Information

Serial Number87822632
Word MarkPEMAZYRE
Filing DateTuesday, March 6, 2018
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, October 22, 2025
Registration Number6086147
Registration DateTuesday, June 23, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders [ ; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 13, 2018
Primary Code005
First Use Anywhere DateMonday, April 20, 2020
First Use In Commerce DateMonday, April 20, 2020

Trademark Owner History

Party NameIncyte Holdings Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19803
Party NameIncyte Holdings Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19803
Party NameIncyte Holdings Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19803

Trademark Events

Event DateEvent Description
Friday, March 9, 2018NEW APPLICATION ENTERED
Tuesday, March 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 26, 2018ASSIGNED TO EXAMINER
Monday, March 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 19, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, December 19, 2018SOU EXTENSION 1 FILED
Wednesday, December 19, 2018SOU EXTENSION 1 GRANTED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019SOU EXTENSION 2 FILED
Tuesday, June 25, 2019SOU EXTENSION 2 GRANTED
Thursday, June 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019SOU TEAS EXTENSION RECEIVED
Monday, November 25, 2019SOU EXTENSION 3 FILED
Monday, November 25, 2019SOU EXTENSION 3 GRANTED
Wednesday, November 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 11, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, April 11, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, April 11, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, April 11, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, April 11, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 11, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 1, 2020TEAS STATEMENT OF USE RECEIVED
Monday, May 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 1, 2020USE AMENDMENT FILED
Tuesday, May 19, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 20, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 21, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 23, 2020REGISTERED-PRINCIPAL REGISTER
Monday, June 23, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 26, 2025TEAS SECTION 8 RECEIVED
Monday, October 20, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 20, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 22, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, October 22, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

pemazyre treatment preparations pharmaceutical disorders skeletal chondrocyte myeloproliferative hypophosphatemia cancer hematological